The data that is shared in the database include "imaging, clinical, genomic, and biomarker data."
"All ADNI data are shared without embargo through the LONI Image and Data Archive (IDA), a secure research data repository. "The application process includes acceptance of the Data Use Agreement and submission of an online application form. The application must include the investigator's institutional affiliation and the proposed uses of the ADNI data. ADNI data may not be used for commercial products or redistributed in any way."
"The Alzheimer's Disease Neuroimaging Initiative (ADNI) is a longitudinal multicenter study designed to develop clinical, imaging, genetic, and biochemical biomarkers for the early detection and tracking of Alzheimer's disease (AD). Since its launch more than a decade ago, the landmark public-private partnership has made major contributions to AD research, enabling the sharing of data between researchers around the world. "Three overarching goals of the ADNI study are: - "To detect AD at the earliest possible stage (pre-dementia) and identify ways to track the disease's progression with biomarkers. - "To support advances in AD intervention, prevention, and treatment through the application of new diagnostic methods at the earliest possible stages (when intervention may be most effective). - "To continually administer ADNI's innovative data-access policy, which provides all data without embargo to all scientists in the world."